Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-volume Metastasis”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)WithdrawnNCT06060587
What this trial is testing

Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

Who this might be right for
Prostate Cancer
Northwestern University
Not applicableLooking for participantsNCT04403867
What this trial is testing

The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.

Who this might be right for
Endometrial CancerCervical CancerSentinel Lymph Node+8 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 500
Not applicableLooking for participantsNCT06661122
What this trial is testing

Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Low-volume Metastasis
Bayer 100
Testing effectiveness (Phase 2)Study completedNCT03828838
What this trial is testing

Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer

Who this might be right for
Prostate Neoplasm
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06347705
What this trial is testing

2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 57
Large-scale testing (Phase 3)Looking for participantsNCT07260435
What this trial is testing

Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Nick Beije 400
Testing effectiveness (Phase 2)Ended earlyNCT00868114
What this trial is testing

Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Leo W. Jenkins Cancer Center 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03436654
What this trial is testing

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 102
Testing effectiveness (Phase 2)Looking for participantsNCT06144736
What this trial is testing

PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND

Who this might be right for
Seminoma
Heinrich-Heine University, Duesseldorf 60
Testing effectiveness (Phase 2)Study completedNCT01558427
What this trial is testing

Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University Hospital, Ghent 62
Testing effectiveness (Phase 2)Looking for participantsNCT07650240
What this trial is testing

Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

Who this might be right for
Recurrent Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8Castration-Sensitive Prostate Cancer+9 more
Mayo Clinic 202
Early research (Phase 1)Looking for participantsNCT06663839
What this trial is testing

NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Light Chain Bioscience - Novimmune SA 25
Large-scale testing (Phase 3)Looking for participantsNCT07241416
What this trial is testing

A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Jiangsu HengRui Medicine Co., Ltd. 206